At Exonbio, we are proud to support this vibrant community through our custom antibody development services, helping researchers unlock new insights into complex neurological targets.
Our Contribution: Antibodies That Recognize Aβ42 Protofibrils
This year, we spotlighted a recent project that exemplifies the power of our platform: the development of antibodies that specifically recognize Aβ42 protofibrils, a key biomarker in Alzheimer’s disease research.
- These antibodies were designed to distinguish protofibrillar forms of Aβ42 from monomers and fibrils
- The results demonstrated high specificity and performance, enabling more precise detection and characterization
- This project reflects our commitment to enabling translational neuroscience through tailored antibody solutions
Whether you are studying neurodegeneration, synaptic biology, or novel CNS targets, Exonbio offers the expertise and flexibility to support your discovery pipeline.
Why Work With Us?
We are a trusted CRO partner for custom antibody development, with a track record of delivering high quality reagents for challenging targets. Our approach combines:
- Collaborative project scoping with scientific teams
- Rapid prototyping and screening workflows
- Transparent communication and milestone based delivery
If you are exploring new targets in neuroscience, we are here to help you move from idea to validation faster and with confidence.
Let’s Collaborate!
Interested in learning more about our Aβ42 project or starting your own antibody development journey?
- Contact us to discuss your neuroscience targets
Looking Ahead
SfN 2025 reminded us of the incredible momentum in neuroscience and the importance of reliable tools to support it. At Exonbio, we remain committed to empowering researchers with custom solutions that drive discovery forward.